Company intelligence / Profile preview

Cerebrotech Medical Systems

Pleasanton, California, United Statesipira.berkeley.edu ↗

Ownership: Private
Development stage: Commercial

Overview

The Visor device has demonstrated the ability to rapidly and non-invasively detect brain fluid asymmetry associated with serious strokes and other neurological events. Clinical studies such as the VITAL trial showed promise for early identification of large vessel occlusion and hemorrhagic strokes. The device received CE Mark approval in Europe and FDA clearance in the US as an aid to neurologic assessment but not yet for specific diagnostic claims.

Therapeutic areas: Neurology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Vastrax (neurovascular clinical research partner)

Beyond the preview

Go deeper on Cerebrotech Medical Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerebrotech Medical Systems.

Explore the full profile